6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00658567 (ClinicalTrials.gov)	March 2008	10/4/2008	A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psycho ...		Parkinson's Disease Psychosis	Drug: Pimavanserin tartrate (ACP-103)	ACADIA Pharmaceuticals Inc.	NULL	Completed	40 Years	N/A	All	123	Phase 3	United States;Austria;Belgium;Italy;Poland;Portugal;Serbia;Spain;Sweden
2	NCT00550238 (ClinicalTrials.gov)	July 2007	26/10/2007	A Study of the Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Diseas ...	A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the ...	Parkinson's Disease Psychosis	Drug: Pimavanserin tartrate (ACP-103)	ACADIA Pharmaceuticals Inc.	NULL	Completed	40 Years	N/A	All	459	Phase 3	United States;Austria;Belgium;Canada;France;India;Italy;Poland;Portugal;Russian Federation;Serbia;Sw ...
3	NCT00477672 (ClinicalTrials.gov)	June 2007	22/5/2007	A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Ps ...	A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of ACP-103 ...	Parkinson's Disease Psychosis	Drug: Pimavanserin tartrate (ACP-103);Drug: Placebo	ACADIA Pharmaceuticals Inc.	NULL	Completed	40 Years	N/A	All	298	Phase 3	United States;Bulgaria;France;India;Russian Federation;Ukraine;United Kingdom
4	NCT01518309 (ClinicalTrials.gov)	November 17, 2004	16/12/2008	An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients	An Open-Label Safety Study of Pimavanserin in Parkinson's Disease Patients	Parkinson's Disease Psychosis	Drug: pimavanserin tartrate (ACP-103)	ACADIA Pharmaceuticals Inc.	NULL	Completed	N/A	N/A	All	39	Phase 2	United States

First Previous1Next Last